CURE19h
Understanding NCCN Guidelines: Gavreto in First-Line RET Fusion NSCLC
Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...
Targeted Oncology5d
Lee Evaluates Chronic GVHD Therapies for Depth and Durability of Response
During a live event, Catherine J. Lee, MD, MS, discussed the efficacy and safety results of various trials of approved agents ...
Medscape1d
Differential Diagnosis of Intrahepatic Bile Duct Dilatation Without Demonstrable Mass On Ultrasonography or CT: Benign Versus Malignancy
Conclusions: Preoperative laboratory data such as alkaline phosphatase and CA19-9, and imaging findings such as significant wall thickening and regional lymph node enlargement on CT, abrupt cut ...
Medscape1d
Voriconazole Therapeutic Drug Monitoring
Background Voriconazole is approved for treatment of invasive aspergillosis and other invasive fungal infections, but the role for therapeutic drug monitoring (TDM) is not clear. Methods We ...